GSE132779
FiT-seq analysis of PDX 14-07 and MMTV-rtTA/tetO/Her2 tumors treated with abemaciclib
We measured changes in H3K27ac after treatment of PDX 14-07 or MMTV-rtTA/tetO-Her2 tumors implanted in nude mice with abemaciclib Overall design: Examination of changes in H3K27ac in PDX 14-07 and MMTV-rtTA/tetO-Her2 tumors after treatment with abemaciclib (90 mg/kg) for 21-28 days (PDX) or 40 days (MMTV-Her2)